Loading company…
Mayoo develops enzymatic DNA synthesis technology, products and services.
Founded in 2022 and based in Shanghai, Mayoo develops enzymatic DNA synthesis technology and provides gene synthesis services. Its products include Gibson Assembly and Golden Gate gene splicing kits and a high-throughput cloning kit. The company closed an angel funding round in June 2024 to support experiments, instrument development and team building.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in